Published in Respiration on January 01, 1982
Pulmonary compliance in sick low birthweight infants. How reliable is the measurement of oesophageal pressure? Arch Dis Child (1983) 1.50
Respiratory compliance in premature babies treated with artificial surfactant (ALEC). Arch Dis Child (1991) 1.01
Accuracy of deadspace free ventilatory measurements for lung function testing in ventilated newborns: a simulation study. J Clin Monit Comput (2000) 0.81
Lung function testing--useless in ventilated newborns? Eur J Pediatr (1994) 0.79
Respiratory outcome in preterm ventilated infants: importance of early respiratory system resistance. Eur J Pediatr (2004) 0.78
Static respiratory compliance in the newborn. I: A clinical and prognostic index for mechanically ventilated infants. Arch Dis Child Fetal Neonatal Ed (1994) 0.78
Ultrasound assessment of ex vivo lung tissue properties using a fluid-filled negative pressure bath. J Biomech Eng (2014) 0.75
Lecithin/sphingomyelin ratio from tracheal aspirates and compliance of the respiratory system in infants with bronchopulmonary dysplasia. Lung (1990) 0.75
Documenting the diet in ancient human populations through stable isotope analysis of hair. Philos Trans R Soc Lond B Biol Sci (1999) 2.66
Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation. Lancet (1998) 2.57
Aminoacid isomerisation and microwave exposure. Lancet (1989) 2.41
Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. Pediatrics (2001) 1.80
Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators. J Am Coll Cardiol (1997) 1.67
Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G. J Pediatr (2000) 1.51
Hydroxyl radical generation in oxygen-treated infants. Pediatrics (1997) 1.46
The cytogenetic basis for classifying ependymomas. J Neuropathol Exp Neurol (1978) 1.44
Effect of lung water content, manipulated by intratracheal furosemide, surfactant, or a mixture of both, on compliance and viscoelastic tissue forces in lung-lavaged newborn piglets. Crit Care Med (2000) 1.41
Preoperative ECMO in congenital cyanotic heart disease using the AREC system. Ann Thorac Surg (1997) 1.41
Clonogenic growth in vitro: an independent biologic prognostic factor in ovarian carcinoma. J Clin Oncol (1991) 1.41
Adjuvant tamoxifen in postmenopausal stage II breast cancer five years on. Lancet (1990) 1.41
D-aminoacids and microwaves. Lancet (1990) 1.39
Ifosfamide/mesna as salvage therapy in platinum pretreated ovarian cancer patients--long-term results of a phase II study. Cancer Invest (2006) 1.39
Type of delivery onset has a significant impact on post-natal mortality in preterm infants of less than 30 weeks' gestation. Acta Paediatr (2014) 1.38
The effect of repeated ozone exposures on inflammatory markers in bronchoalveolar lavage fluid and mucosal biopsies. Am J Respir Crit Care Med (2000) 1.36
Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences. Hum Reprod (2012) 1.30
Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis Suppl (1992) 1.28
Ultrasensitive bioanalytical assays using time-resolved fluorescence detection. Pharmacol Ther (1995) 1.24
L-arginine increases exhaled nitric oxide in normal human subjects. Clin Sci (Lond) (1995) 1.22
Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome. J Neural Transm Suppl (2001) 1.22
Eosinophilic differentiation of the human promyelocytic leukemia cell line, HL-60. J Exp Med (1984) 1.22
Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation. Br Heart J (1995) 1.21
Protein expression of BACE1, BACE2 and APP in Down syndrome brains. Amino Acids (2007) 1.16
The Ice Man's diet as reflected by the stable nitrogen and carbon isotopic composition of his hair. FASEB J (1999) 1.15
Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1. Allergy (2006) 1.12
Association between congenital toxoplasmosis and preterm birth, low birthweight and small for gestational age birth. BJOG (2005) 1.11
Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer's disease. Biochem Biophys Res Commun (2001) 1.10
Recent trends in research on congenital toxoplasmosis. Int J Parasitol (2001) 1.10
Fetal life in Down syndrome starts with normal neuronal density but impaired dendritic spines and synaptosomal structure. J Neural Transm Suppl (2001) 1.09
Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters. Am J Obstet Gynecol (1999) 1.09
A new europium chelate for protein labelling and time-resolved fluorometric applications. Clin Biochem (1988) 1.08
Toxopert-I: knowledge-based automatic interpretation of serological tests for toxoplasmosis. Comput Methods Programs Biomed (1997) 1.05
Safety evaluation of piperacillin/tazobactam in very low birth weight infants. J Chemother (2004) 1.04
Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down syndrome. Electrophoresis (2001) 1.03
Prognostic value of the rupture of the capsule in stage I epithelial ovarian carcinoma. Gynecol Oncol (1989) 1.03
Central venous catheter mechanical irritation of the right atrial free Wall:A cause for thrombus formation. Cardiology (1999) 1.02
Time-resolved detection of lanthanide luminescence for ultrasensitive bioanalytical assays. J Photochem Photobiol B (1995) 1.02
Zinc deficiency induces enhanced depression-like behaviour and altered limbic activation reversed by antidepressant treatment in mice. Amino Acids (2008) 1.02
Transvenous pacemaker leads do not worsen tricuspid regurgitation: a prospective echocardiographic study. Cardiology (2000) 1.02
Ecological comparison of the risks of mother-to-child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment protocol. Epidemiol Infect (2001) 1.01
Postmortem changes in the level of brain proteins. Exp Neurol (2001) 1.00
Minimally differentiated acute nonlymphocytic leukemia: a distinct entity. Blood (1987) 1.00
Collagenous colitis and rheumatoid arthritis with response to sulfasalazine. A case report and review of the literature. J Clin Gastroenterol (1987) 1.00
The reduction of NADH ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease. Life Sci (2001) 1.00
[Opiate addiction in gravidity - consequences for the newborn. Results of an interdisciplinary treatment concept]. Z Geburtshilfe Neonatol (2001) 0.99
Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease. Biochem Biophys Res Commun (2001) 0.99
On the origin of extracellular glutamate levels monitored in the basal ganglia of the rat by in vivo microdialysis. J Neurochem (1996) 0.99
Autotaxin (NPP-2) in the brain: cell type-specific expression and regulation during development and after neurotrauma. Cell Mol Life Sci (2007) 0.98
Expression of apoptosis related proteins in brains of patients with Alzheimer's disease. Neurosci Lett (2001) 0.98
Diagnosis of congenital toxoplasmosis in the neonatal period: A multicenter evaluation. J Pediatr (1999) 0.97
Decreased brain levels of 2',3'-cyclic nucleotide-3'-phosphodiesterase in Down syndrome and Alzheimer's disease. Neurobiol Aging (2001) 0.97
Protein expression in Down syndrome brain. Amino Acids (2001) 0.96
Follow-up of infants with congenital toxoplasmosis detected by polymerase chain reaction analysis of amniotic fluid. Eur J Clin Microbiol Infect Dis (1998) 0.96
Neonatal colonization of mice with Lactobacillus plantarum producing the aeroallergen Bet v 1 biases towards Th1 and T-regulatory responses upon systemic sensitization. Allergy (2010) 0.96
Long-term experience with subcutaneously tunneled external ventricular drainage in preterm infants. Childs Nerv Syst (2000) 0.95
Differences between GABA levels in Alzheimer's disease and Down syndrome with Alzheimer-like neuropathology. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.95
[Collagenolytic activity of neoplastic and rapidly proliferating normal tissue]. Onkologie (1981) 0.95
Pregnancy-related changes of carnitine and acylcarnitine concentrations of plasma and erythrocytes. J Perinat Med (1995) 0.95
Aberrant expression of dihydropyrimidinase related proteins-2,-3 and -4 in fetal Down syndrome brain. J Neural Transm Suppl (2001) 0.94
Biochemical and morphological effects of human hepatic alkaline phosphatase in a neonate with hypophosphatasia. Acta Paediatr Scand Suppl (1989) 0.94
L-Arginine reduces lipid peroxidation in patients with diabetes mellitus. Free Radic Biol Med (1997) 0.93
The pharmacologic effects of furosemide therapy in the low-birth-weight infant. J Pediatr (1978) 0.93
Decreased levels of complex III core protein 1 and complex V beta chain in brains from patients with Alzheimer's disease and Down syndrome. Cell Mol Life Sci (2000) 0.93
Influence of the route of sensitization on local and systemic immune responses in a murine model of type I allergy. Clin Exp Immunol (2004) 0.93
First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer. Br J Cancer (1993) 0.93
Effect of tracheal suction on oxygenation, circulation, and lung mechanics in newborn infants. Arch Dis Child (1981) 0.92
Tuberin activates the proapoptotic molecule BAD. Oncogene (2006) 0.92
Increased levels of 14-3-3 gamma and epsilon proteins in brain of patients with Alzheimer's disease and Down syndrome. J Neural Transm Suppl (1999) 0.92
Aberrant protein expression in cerebral cortex of fetus with Down syndrome. Neuroscience (2003) 0.92
In vivo gammadelta T cell priming to mycobacterial antigens by primary Mycobacterium tuberculosis infection and exposure to nonpeptidic ligands. Mol Med (1999) 0.92
Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part III). Amino Acids (2003) 0.91
Hepatitis B vaccination and immune response in children with malignant diseases. Eur J Pediatr (1985) 0.91
Inadvertent positive end-expiratory pressure in mechanically ventilated newborn infants: detection and effect on lung mechanics and gas exchange. J Pediatr (1986) 0.91
[The correlation between lh determination in the urine (Luteonosticon and JI-Gonavis) and serum LH, FSH, oestradiol, progesterone, testosterone and prolactin levels at midcycle. (author's transl)]. Wien Klin Wochenschr (1979) 0.91
Microparticle enzyme immunoassay (MEIA) for toxoplasma specific immunoglobulin G in comparison to the Sabin-Feldman dye test. A pilot study. Wien Klin Wochenschr (1995) 0.91
p25 protein in neurodegeneration. Nature (2001) 0.91
Heart rate variability during chronic hemodialysis and after renal transplantation: studies in patients without and with systemic amyloidosis. J Am Soc Nephrol (1999) 0.91
Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: Challenging the gene dosage effect hypothesis (Part IV). Amino Acids (2003) 0.91
Tamoxifen in refractory ovarian cancer: the use of a loading dose schedule. Br J Cancer (1988) 0.91
Renal functions of low birth weight infants with hyperglycemia and glucosuria produced by glucose infusions. Pediatrics (1980) 0.91
Two-dimensional map of human brain proteins. Electrophoresis (1999) 0.91
Oral administration of methylglyoxal leads to kidney collagen accumulation in the mouse. Life Sci (1998) 0.90
Fine structure of medulloepithelioma. J Neuropathol Exp Neurol (1977) 0.90
Evaluation of the Cerebral Function Monitor as a tool for neurophysiological surveillance in neonatal intensive care patients. Childs Nerv Syst (2001) 0.90
Decreased brain histamine-releasing factor protein in patients with Down syndrome and Alzheimer's disease. Neurosci Lett (2001) 0.90
Reduced susceptibility of nonenzymatically glucosylated glomerular basement membrane to proteases: is thickening of diabetic glomerular basement membranes due to reduced proteolytic degradation? Ren Physiol (1980) 0.90
Identification and characterisation of soluble epoxide hydrolase in mouse brain by a robust protein biochemical method. Amino Acids (2005) 0.89
Urinary excretion of glomerular basement membrane antigens in Alport's syndrome. A new diagnostic approach. Arch Dis Child (1978) 0.89
Deranged hypothetical proteins Rik protein, Nit protein 2 and mitochondrial inner membrane protein, Mitofilin, in fetal Down syndrome brain. Cell Mol Biol (Noisy-le-grand) (2003) 0.89
Aberrant expression of cytoskeleton proteins in hippocampus from patients with mesial temporal lobe epilepsy. Amino Acids (2006) 0.89
Apoptosis-associated proteins p53 and APO-1/Fas (CD95) in brains of adult patients with Down syndrome. Neurosci Lett (1999) 0.89
Delayed neuronal death following perinatal asphyxia in rat. Exp Brain Res (1997) 0.88
Increased brain protein levels of carbonyl reductase and alcohol dehydrogenase in Down syndrome and Alzheimer's disease. J Neural Transm Suppl (2001) 0.88
Decreased levels of ARPP-19 and PKA in brains of Down syndrome and Alzheimer's disease. J Neural Transm Suppl (2001) 0.88
Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part II). Amino Acids (2003) 0.88